A qualitative study on the adverse reactions of mass treatment for lymphatic filariasis in Orissa, India
Author:
- Bv BabuBBBv Babu
Open Access
- 1 January 2010
- journal article
- Published by Medknow in Asian Pacific Journal of Tropical Medicine
- Vol. 3 (1) , 55-58
Abstract
ObjectiveTo describe the perceptions of community members and programme partners regarding severity, management and impact of adverse reactions on mass drug administration (MDA) compliance.MethodsBased on various qualitative data collected from five districts of Orissa, India, where MDA had been implemented during 2002 and 2004. The qualitative surveys included focus group discussions with community members and health workers, and semi-structured interviews with key informants in the community, medical officers at primary health centres, district level health officers and private practitioners.ResultsIt showed that many people suffered from adverse reactions, though the reactions were not serious. The paper reported different ways of management of adverse reactions at the community level. The impact of adverse reactions on MDA compliance was serious, as many people did not consume the drug due to fear of adverse reactions. The rumours of adverse reactions and news in media deterred people from consuming the tablets.ConclusionAll categories of respondents indicates the need of more information to address the problem of adverse reactions during MDA. The present paper warrants incorporating the messages on adverse reactions during health communication and social mobilization campaigns of MDAKeywords
This publication has 18 references indexed in Scilit:
- Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, IndiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, IndiaTropical Medicine & International Health, 2004
- Mass Treatment to Eliminate Filariasis in Papua New GuineaNew England Journal of Medicine, 2002
- Drug Treatment of Tropical Parasitic InfectionsDrugs, 2000
- Editorial: The Global Programme to Eliminate Lymphatic FilariasisTropical Medicine & International Health, 2000
- Onchocerciasis control in Uganda: how can self-sustaining, community-based treatment with ivermectin be achievedPathogens and Global Health, 1998
- Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian childrenThe Lancet, 1997
- Evaluation of ivermectin distribution in Benin, Cote d'Ivoire, Ghana and Togo: estimation of coverage of treatment and operational aspects of the distribution systemPathogens and Global Health, 1997
- Intestinal worms beware: Developments in anthelmintic chemotherapy usageParasitology Today, 1997
- Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of Bancroftian filariasis, Recife, BrazilTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994